Skip to main content
Premium Trial:

Request an Annual Quote

Henry Schein to Distribute Cepheid GeneXpert in the US

NEW YORK (GenomeWeb) – Cepheid has signed a non-exclusive distribution agreement with Henry Schein Medical — the US health care products and services business of Henry Schein, Inc. — for the GeneXpert molecular diagnostics system and associated tests, the company announced today. Terms of the deal were not disclosed

The agreement focuses on the GeneXpert and test portfolio, including an influenza and respiratory syncytial virus assay that was CLIA waived in December. It expands distribution of the GeneXpert platform and menu of 17 Xpert tests beyond the traditional hospital lab space, according to Cepheid.

"Our relationship with Henry Schein opens an immediate opportunity for GeneXpert System placements in more than 10,000 moderately complex labs outside the hospital," said Cepheid's Chief Medical and Technology Officer David Persing in a statement.  

The non-acute care lab market reached by the Henry Schein distribution network includes physicians’ office labs, women’s health clinics, urgent care facilities, community health centers, correctional facilities, student health centers, STD clinics, long-term care facilities, and reference labs.

Henry Schein will also distribute Cepheid's point-of-care molecular platform, the GeneXpert Omni, subject to US Food and Drug Administration approval of the new platform and associated tests. The firm anticipates launching the Omni in late 2016, with Henry Schein providing access to more than 100,000 CLIA-waived physician office laboratories, Persing added.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.